Advertisement

Topics

GSK's new President of Global Pharma join date revealed as AZ drops lawsuit

05:10 EDT 20 Jun 2017 | Pharmafile

The transition of former AstraZeneca Executive Vice President for Europe Luke Miels to rival pharma giant GlaxoSmithKline has not been a smooth one. Miels left AZ in January to join GSK as the firm’s President of Global Pharmaceuticals, only to face a lawsuit from his former employer over allegations he breached the terms of his contract.

read more

Original Article: GSK's new President of Global Pharma join date revealed as AZ drops lawsuit

NEXT ARTICLE

More From BioPortfolio on "GSK's new President of Global Pharma join date revealed as AZ drops lawsuit"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...